Baird adds VP to West End office

Institutional consultant comes with more than two decades of experience
Aug 25, 2015 7:16 AM

Baird cuts Genesco rating

Analysts at Robert W. Baird have taken their rating for Genesco down a notch to 'neutral' from 'outperform.' The firm now sees shares of the Nashville-based retailer of shoes and other apparel (Ticker: GCO) climbing to $76 from their current level of $71 and change. Year to date, the stock is off about 7 percent.

SEE ALSO: Genesco looks to fix Macy's growing pains

Apr 1, 2015 9:48 AM

Baird starts HealthStream at neutral

Analysts at Robert W. Baird have launched coverage of HealthStream shares with a 'neutral' rating and a price target of $27. That leaves less than 10 percent of upside from where the shares (Ticker: HSTM) are changing hands today. They're down about 15 percent year to date.

Mar 19, 2015 11:44 AM

HCA, analysts lift hospital stocks

Q3 beat from Nashville's biggest company affirms benefits of health reform
Oct 16, 2014 2:50 PM

Analyst action: Pinnacle, Clarcor

Kevin Reynolds at Wunderlich Securities has raised his price target for shares of Pinnacle Financial Partners to $40 from $37 after the bank holding company reported its Q2 numbers. Reynolds says investors shouldn't put too much stock in the earnings beat because of a smaller loan loss provision, but he nonetheless likes Pinnacle's long-term prospects. Pinnacle shares (Ticker: PNFP) closed Thursday trading at $36.05 and are up 11 percent so far in 2014.

At Robert W. Baird, analyst Richard Eastman has hiked his rating on Clarcor shares to 'outperform' from 'neutral,' citing better fundamentals, the benefit of recent acquisitions and a decent valuation. He sees Clarcor (Ticker: CLC), which closed Thursday at $60.46, climbing to $67 in the coming quarters.

Jul 18, 2014 7:19 AM

Baird upgrades AmSurg rating, price target

Robert W. Baird analyst Whit Mayo upgraded his AmSurg rating Friday to 'outperform' from 'neutral.' Mayo also boosted his price target for the company to $55 from $44.

Shares of the ambulatory surgery company (Ticker: AMSG) were down nearly 10 percent last week, following news that the company is offering almost 10 million shares to finance its acquisition of Sheridan Healthcare. Year to date, shares are down slightly. However, they're up 28 percent in the last 12 months.

Jun 29, 2014 10:00 PM

Tractor Supply's bullish defenders help limit the damage

A couple of analysts following Tractor Supply said Thursday that investors shouldn't overreact to the company's so-so 2014 guidance, which initially pushed down its shares by more than 5 percent. At Robert W. Baird, Peter Benedict says the company's fundamentals are strong enough to endure and that this pullback has created a good buying opportunity. Wells Fargo's Matt Nemer, meanwhile, expects the relatively bad news to be quickly surpassed by strong January numbers.

Those comments appear to have helped Tractor Supply investors quickly find a bottom Thursday and climb from there. At about 1:40 p.m., the stock (Ticker: TSCO) was down just 2 percent on the day on volume that was on track to be the double the average.

Jan 30, 2014 1:33 PM

CHS chief pounds table on Medicaid expansion

Health Care Council panelists expect change, with rural stakeholders leading the way
Jan 22, 2014 2:22 PM

Analyst action: Clarcor, Healthcare Realty

Richard Eastman at Robert W. Baird says investors should take a more cautious stance on Clarcor following the Franklin-based filtration company's earnings report. He has cut his rating to 'neutral' from 'outperform' and trimmed his price target to $59 from $62. Clarcor (Ticker: CLC) was changing hands at $58.40 in early Friday trading.

Analysts at JPMorgan have similarly lowered their opinion of Healthcare Realty Trust to 'neutral' from 'overweight' and taken down their target to $23 from $26. Shares of Healthcare Realty (Ticker: HR) were down slightly at $22.32 this morning. They've fallen about 8 percent in the past three months.

Jan 17, 2014 10:28 AM

eMids raises more than $13M

Nashville-based eMids Technologies has secured its first institutional investment, a $13.3 million round from Council Capital and Robert W. Baird's private-equity group. President and CEO Saurab Sinha tells E.J. Boyer he plans to use some of the cash to buy other health care technology consulting firms: "Given the momentum in the industry and what we were seeing our competitors do, we felt like we had a window to grow even more rapidly. That's sort of made us decide in going down this route and being a little more aggressive about this state of growth."

Dec 5, 2013 6:58 AM